Clinical Trial Update: Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

View source ↗

Summary

Expanded Access treatment program for Critical Limb Ischemia with minor tissue loss in patients unsuitable for revascularization is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Snippet

Sponsor: Pluristem Ltd. | Conditions: Critical Limb Ischemia (CLI) | Status: NO_LONGER_AVAILABLE